These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3092848)
1. Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia. Ording H; Nielsen VG Br J Anaesth; 1986 Sep; 58(9):1001-4. PubMed ID: 3092848 [TBL] [Abstract][Full Text] [Related]
2. Use of vecuronium and doxapram in patients susceptible to malignant hyperthermia. Ording H; Fonsmark L Br J Anaesth; 1988 Mar; 60(4):445-9. PubMed ID: 2895665 [TBL] [Abstract][Full Text] [Related]
3. Glycopyrrolate intensifies neuromuscular blockade produced by atracurium in the rat diaphragm preparation. Wali FA; Dark CH; Altinel A; Jones CJ Pharmacol Res Commun; 1987 Nov; 19(11):827-35. PubMed ID: 3444844 [TBL] [Abstract][Full Text] [Related]
4. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block. Whalley DG; Lewis B; Bedocs NM Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941 [TBL] [Abstract][Full Text] [Related]
5. Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies. Mezin P; Payen JF; Bosson JL; Brambilla E; Stieglitz P Br J Anaesth; 1997 Sep; 79(3):327-31. PubMed ID: 9389850 [TBL] [Abstract][Full Text] [Related]
6. Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients. Fiege M; Wappler F; Scholz J; Weisshorn R; von Richthofen V; Schulte am Esch J J Clin Anesth; 2000 Mar; 12(2):123-8. PubMed ID: 10818326 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of malignant hyperthermia susceptibility. 1. The significance of in vitro susceptibility tests]. Mortier W; Breucking E Anaesthesist; 1993 Oct; 42(10):675-83. PubMed ID: 8250201 [TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone]. Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864 [TBL] [Abstract][Full Text] [Related]
9. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy. Martin-Flores M; Paré MD; Campoy L; Gleed RD Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854 [TBL] [Abstract][Full Text] [Related]
10. Antagonism of atracurium-induced neuromuscular blockade by neostigmine or edrophonium. Astley BA; Hughes R; Payne JP Br J Anaesth; 1986 Nov; 58(11):1290-5. PubMed ID: 3778793 [TBL] [Abstract][Full Text] [Related]
11. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia. Ording H; Bendixen D Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of the phosphodiesterase-III inhibitor enoximone on malignant hyperthermia-susceptible swine. Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte Am Esch J Anesthesiology; 2003 Apr; 98(4):944-9. PubMed ID: 12657857 [TBL] [Abstract][Full Text] [Related]
13. Desflurane is a trigger of malignant hyperthermia in susceptible swine. Wedel DJ; Iaizzo PA; Milde JH Anesthesiology; 1991 Mar; 74(3):508-12. PubMed ID: 1900398 [TBL] [Abstract][Full Text] [Related]
14. Results of in vitro contracture testing of both parents of malignant hyperthermia susceptible probands. Islander G; Bendixen D; Ranklev-Twetman E; Ording H Acta Anaesthesiol Scand; 1996 May; 40(5):579-84. PubMed ID: 8792888 [TBL] [Abstract][Full Text] [Related]
15. Evoked electromyographic and mechanical responses of the adductor pollicis compared during the onset of neuromuscular blockade by atracurium or alcuronium, and during antagonism by neostigmine. Harper NJ; Bradshaw EG; Healy TE Br J Anaesth; 1986 Nov; 58(11):1278-84. PubMed ID: 3778792 [TBL] [Abstract][Full Text] [Related]
16. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia]. Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614 [TBL] [Abstract][Full Text] [Related]
17. Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Comparison of neostigmine with edrophonium. Caldwell JE; Robertson EN; Baird WL Br J Anaesth; 1986 Nov; 58(11):1285-9. PubMed ID: 2877681 [TBL] [Abstract][Full Text] [Related]
18. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory. Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556 [TBL] [Abstract][Full Text] [Related]
19. Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia. Gerbershagen MU; Wappler F; Fiege M; Kolodzie K; Weisshorn R; Szafarczyk W; Kudlik C; Schulte Am Esch J Br J Anaesth; 2003 Aug; 91(2):281-4. PubMed ID: 12878630 [TBL] [Abstract][Full Text] [Related]
20. Inositol 1,4,5-trisphosphate in blood and skeletal muscle in human malignant hyperthermia. Wappler F; Scholz J; Köchling A; Steinfath M; Krause T; Schulte am Esch J Br J Anaesth; 1997 May; 78(5):541-7. PubMed ID: 9175969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]